Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD (original) (raw)
Related papers
Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary Disease
JAMA, 2013
Biomarkers in obstructive respiratory diseases: An update
Panminerva medica
Towards the next stage of novel biomarker discussion in COPD: Tekizai-Tekisho
European Respiratory Journal, 2014
Journal of Medical Biochemistry
Primary Care Respiratory Journal, 2007
Diagnosis, assessment, and phenotyping of COPD: beyond FEV1
International Journal of Chronic Obstructive Pulmonary Disease, 2016
Proceedings of the American Thoracic Society, 2006
LATE-BREAKING ABSTRACT: Biomarkres in exacerbations of chronic obstructive pulmonary disease (ECOPD)
European Respiratory Journal, 2016
The Clinical …, 2008
Diagnostic Utility of Biomarkers in COPD
Respiratory Care, 2015
Exhaled Nitric Oxide as a Biomarker in COPD and Related Comorbidities
Fabio Ricciardolo, Beatrice Ragnoli
BioMed Research International, 2014
C-reactive protein correlates with tissue oxygen availability in patients with stable COPD
… journal of chronic …, 2008
Markers of disease severity in chronic obstructive pulmonary disease
Pulmonary Pharmacology & Therapeutics, 2006
International Journal of Chronic Obstructive Pulmonary Disease, 2020
Treatment response in COPD: does FEV1 say it all? A post hoc analysis of the CRYSTAL study
ERJ Open Research, 2019
2019
Profiling serum biomarkers in patients with COPD: associations with clinical parameters
Thorax, 2007
Annals of Medical Research, 2021
PLoS ONE, 2012
The clinical respiratory journal, 2008
Pulmonary Pharmacology & Therapeutics, 2010
Factors That May Affect FEV1 Change Of COPD Patients In One-Year Period
2020
Determination of inflammatory biomarkers in patients with COPD: a comparison of different assays
BMC Medical Research Methodology, 2012
Serial Measurements of Arterial Oxygen Tension are Associated with Mortality in COPD
COPD: Journal of Chronic Obstructive Pulmonary Disease, 2014
Global assessment of the COPD patient: Time to look beyond FEV1?
Respiratory Medicine, 2009
Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Pulmonary function testing in COPD: looking beyond the curtain of FEV1
npj Primary Care Respiratory Medicine, 2021
Annals of the American Thoracic Society, 2017
Inflammatory and immunological profiles in patients with COPD: relationship with FEV 1 reversibility
Jornal Brasileiro de Pneumologia, 2016
PLoS ONE, 2012